Non-Hodgkin's Lymphoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Boy lives long enough to meet new baby sister before passing away ... - The Independent



The Independent
 
Boy lives long enough to meet new baby sister before passing away ... 
The Independent
When nine-year-old Bailey Cooper was told by doctors that he only had days or weeks to live, he was determined to hold on long enough to meet his new baby sister. Despite the fact that cancer had spread throughout his entire body, Bailey was able to ...
Bailey Cooper pictured holding sister day before he died | Daily Mail ... Daily Mail
Heartbreaking moment terminal cancer boy, 9, cradled newborn baby sister a day before he died after vowing to live ... The Sun
Boy, 9, Holds His Newborn Baby Sister Before Dying of Cancer NBC4i.com
The Times  -News.Az  -Bristol Post 
all 15 news articles » 


Lymphoma Advisor - Cancer Therapy Advisor



Cancer Therapy Advisor
 
Lymphoma Advisor 
Cancer Therapy Advisor
In this question-and-answer session, Dr Dreyling discusses research presented at the 2017 American Society of Hematology (ASH) Annual Meeting likely to have a clinical impact among patients with NHL. Cancer Therapy Advisor (CTA): Please explain the ...

 


Two cases of non-Hodgkin lymphoma of urinary bladder: Primary and secondary. - UroToday



Two cases of non-Hodgkin lymphoma of urinary bladder: Primary and secondary. 
UroToday
Lymphoma of urinary bladder is rare and can be primary (0.2% of all bladder neoplasms) or secondary (1.8% of secondary tumors of the bladder), the latter being more common. Here, we report a case each of primary and secondary lymphoma of the bladder ...

 


Axi-Cel Plus Atezolizumab Active, Safe in DLBCL - OncLive



OncLive
 
Axi-Cel Plus Atezolizumab Active, Safe in DLBCL 
OncLive
The ZUMA-6 trial is aimed at building on the success of the ZUMA-1 trial, in which the CR rate was 40% with a median follow-up of 15.4 months for patients with refractory, aggressive non-Hodgkin lymphoma (NHL) treated with axi-cel.2 Forty-two percent ...

 


Link between NYC cancer cluster and Chernobyl disaster - Medical Xpress



Link between NYC cancer cluster and Chernobyl disaster 
Medical Xpress
When four ophthalmology and oncology practices in New York City diagnosed 10 patients with ultra-rare vitreoretinal lymphoma (VRL) during a four-year period, the doctors' curiosity piqued: VRL is an unusual presentation of the already-rare primary ...

 


For Kids' Sake Foundation plans Heart of Gold Gala - Wicked Local Bellingham



For Kids' Sake Foundation plans Heart of Gold Gala 
Wicked Local Bellingham
PLAINVILLE -- With Valentine's Day just around the corner, For Kids' Sake Foundation is hosting the Heart of Gold Gala on Feb. 10, 7 p.m. at An Unlikely Story, 111 South St., Plainville. The goal of the event is to raise $10,000 for pediatric cancer ...

and more » 


Hodgkin's lymphoma: Grandmother becomes third generation of same family to be diagnosed with blood cancer strain - The Independent



The Independent
 
Hodgkin's lymphoma: Grandmother becomes third generation of same family to be diagnosed with blood cancer strain 
The Independent
Thankfully after an operation to remove the tumour and a course of intense chemotherapy, Jessica's cancer has gone. The student, who is studying to be an optician in Birmingham, was forced to defer for a year to undergo the gruelling therapy. However ...
Mum and daughter struck by cancer five years apart devastated after grandma is diagnosed with same disease Mirror.co.uk

all 3 news articles » 


Forty Seven lines up Roche as second partner for CD47 cancer ... - FierceBiotech



FierceBiotech
 
Forty Seven lines up Roche as second partner for CD47 cancer ... 
FierceBiotech
Forty Seven has added Roche to its partner list for CD47-targeted immuno-oncology candidate, with Roche's Genentech unit agreeing to sponsor two trials of the antibody in combination with its PD-L1 inhibitor Tecentriq. It's the second I-O partnership ...
Stanford Spinout Partners with Merck KGaA, Genentech in Cancer ... Genetic Engineering & Biotechnology News

all 2 news articles » 


CAR T-cell therapies in treating lymphoma: Pros and cons - ModernMedicine



CAR T-cell therapies in treating lymphoma: Pros and cons 
ModernMedicine
Catherine Bollard, MD, director of the Center for Cancer and Immunology Research at Washington, D.C.-based Children's National Health System, discussed immunotherapy for non-Hodgkin's lymphoma at the 2017 American Society of Hematology (ASH) annual ...

 


Heartbreaking photo shows beaming smile of dying boy who battled cancer long enough to meet baby sister - Mirror.co.uk



Mirror.co.uk
 
Heartbreaking photo shows beaming smile of dying boy who battled cancer long enough to meet baby sister 
Mirror.co.uk
At Easter, the family went off to a holiday park in Devon for Bailey's first holiday, courtesy of charity Clic Sargent. He had just done his first MRI and the doctors were confident. Lee said: ?On the second day, we were in Paignton Zoo when we had a ...

and more »